Počet záznamov: 1
Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience
SYS 0082362 LBL 00000naa^^22^^^^^^^^450 005 20131018102418.0 100 $a 20121108a2012 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Gemcitabine and cisplatin combination chemotherapy in triple negative metastatic breast cancer previously treated with a taxane/anthracycline chemotherapy; multicenter experience $f M. Ozkan ... [et al.] 215 $c ilustr., grafy, tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0078214 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 59, no. 1 (2012), s. 38-42 $1 210 $a Bratislava $c AEPress $d 2012 $1 215 $a s. 1-120 541 1-
$a Kombinovaná chemoterapia gemcitabín a cisplatina trojnásobne negatívneho metastatického karcinómu prsníka predtým liečeného chemoterapiou s taxán/antracyklínmi; multicentrická skúsenosť $z slo 606 1-
$3 sllk_un_auth*d001943 $a nádory prsníka $x farmakoterapia $x patológia $2 mesh 606 1-
$3 sllk_un_auth*d009362 $a metastázy nádorové $2 mesh 606 1-
$3 sllk_un_auth*d004359 $a farmakoterapia kombinovaná $2 mesh 606 2-
$3 sllk_un_auth*d002945 $a cisplatina $x aplikácia a dávkovanie $x toxicita $2 mesh 606 2-
$3 sllk_un_auth*d018943 $a antracyklíny $2 mesh 606 2-
$3 sllk_un_auth*d018572 $a prežívanie bez choroby $2 mesh 606 2-
$3 sllk_un_auth*d016896 $a výsledok liečby $2 mesh 610 2-
$a karcinóm prsníka metastatický 610 2-
$a kombinácia gemcitabín a cisplatina 701 -1
$3 sllk_un_auth*0001877 $a Ozkan $b M. $p Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey $4 070 701 -1
$3 sllk_un_auth*0027300 $a Berk $b V. $p Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey $4 070 701 -1
$3 sllk_un_auth*0026368 $a Kaplan $b M. A. $p Department of Medical Oncology, Dicle University, Diyarbakir, Turkey $4 070 701 -1
$3 sllk_un_auth*0001885 $a Benekli $b M. $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 070 701 -1
$3 sllk_un_auth*p0066022 $a Coskun $b U. $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 070 701 -1
$3 sllk_un_auth*0027301 $a Bilici $b A. $p Department of Medical Oncology, Kartal Training and Research Hospital, Istambul, Turkey $4 070 701 -1
$3 sllk_un_auth*0027302 $a Gumus, M. $p Department of Medical Oncology, Kartal Training and Research Hospital, Istambul, Turkey $4 070 701 -1
$3 sllk_un_auth*0027303 $a Alkis, N. $p Deparment od Medical Oncology, Ankara Oncology Hospital, Ankara, Turkey $4 070 701 -1
$3 sllk_un_auth*0026383 $a Dane $b F. $p Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey $4 070 701 -1
$3 sllk_un_auth*0026372 $a Ozdemir $b N. $p Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey $4 070 701 -1
$3 sllk_un_auth*0027304 $a Colak $b D. $p Deparment of Medical Oncology, Yildirim Beyazit Training and Research Hospital, Ankara $4 070 701 -1
$3 sllk_un_auth*0001878 $a Dikilitas $b M. $p Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey $4 070 801 -0
$a SK $b BA006 $c 20121108 $g AACR2
Počet záznamov: 1